Adalat: Advanced Blood Pressure and Angina Control
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.50 | $45.20 (0%) | 🛒 Add to cart |
| 120 | $0.43 | $60.27 $51.23 (15%) | 🛒 Add to cart |
| 180 | $0.35 | $90.41 $63.28 (30%) | 🛒 Add to cart |
| 270 | $0.30 | $135.61 $81.36 (40%) | 🛒 Add to cart |
| 360 | $0.27
Best per pill | $180.81 $97.44 (46%) | 🛒 Add to cart |
Adalat, known generically as nifedipine, is a leading calcium channel blocker prescribed for the management of hypertension and chronic stable angina. It functions by relaxing and widening blood vessels, thereby improving blood flow and reducing cardiac workload. This medication is a cornerstone in cardiovascular therapy, offering reliable and sustained control for patients requiring long-term management of these conditions. Its well-established efficacy and safety profile make it a trusted choice among healthcare professionals worldwide.
Features
- Active ingredient: Nifedipine
- Available in extended-release formulations for 24-hour coverage
- Multiple dosage strengths (e.g., 30 mg, 60 mg, 90 mg)
- Oral administration, typically once daily
- Proven bioavailability and consistent pharmacokinetic profile
Benefits
- Effectively lowers high blood pressure, reducing the risk of stroke, heart attack, and kidney damage.
- Decreases the frequency and severity of angina attacks, improving exercise tolerance and quality of life.
- Provides smooth, around-the-clock blood pressure control with once-daily dosing.
- Minimizes vascular resistance without significantly affecting heart rate in most patients.
- Supported by decades of clinical use and extensive research affirming its safety and effectiveness.
- Helps prevent long-term cardiovascular complications when used as part of a comprehensive treatment plan.
Common use
Adalat is primarily indicated for the management of hypertension (high blood pressure) and chronic stable angina pectoris. It may be used as monotherapy or in combination with other antihypertensive agents, such as beta-blockers or ACE inhibitors, depending on individual patient needs and response. In some cases, it may also be prescribed for Raynaud’s phenomenon or off-label for certain other vascular conditions, under strict medical supervision.
Dosage and direction
The dosage of Adalat must be individualized based on the patient’s clinical response and tolerance. For hypertension or angina, the typical starting dose for the extended-release formulation is 30 mg or 60 mg orally once daily. Dosage may be adjusted at intervals of 7 to 14 days, with a maximum recommended dose of 90 mg daily. Tablets should be swallowed whole, without crushing or chewing, and may be taken with or without food. Consistency in daily administration time is recommended to maintain stable blood levels. Dosage adjustments are particularly important in elderly patients or those with hepatic impairment.
Precautions
Patients taking Adalat should avoid grapefruit or grapefruit juice, as it can increase blood levels of nifedipine and the risk of adverse effects. Blood pressure should be monitored regularly, especially after initiating therapy or adjusting the dose. Use with caution in patients with heart failure, severe aortic stenosis, or severe hypotension. Abrupt discontinuation should be avoided, as it may lead to rebound hypertension or worsening angina. Patients should be advised to rise slowly from a sitting or lying position to minimize the risk of dizziness or syncope due to orthostatic hypotension.
Contraindications
Adalat is contraindicated in patients with known hypersensitivity to nifedipine or any component of the formulation. It must not be used in individuals with cardiogenic shock, clinically significant aortic stenosis, or during acute myocardial infarction (especially within the first 2 weeks). Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) is also contraindicated due to the risk of severe hypotension and other adverse reactions.
Possible side effect
Common side effects include peripheral edema, headache, dizziness, flushing, and fatigue. Less frequently, patients may experience palpitations, nausea, constipation, or muscle cramps. Although rare, serious adverse effects can include hypotension, syncope, worsening angina, or heart failure. Significant hypotension may occur particularly during initial titration or upon dosage increase. Any persistent or severe side effects should be promptly reported to a healthcare provider.
Drug interaction
Adalat may interact with several medications. Strong inhibitors of CYP3A4 (e.g., clarithromycin, itraconazole) can significantly increase nifedipine levels. Conversely, CYP3A4 inducers (e.g., rifampin, phenytoin) may decrease its efficacy. Concurrent use with beta-blockers may increase the risk of heart failure or severe hypotension. Adalat can potentiate the effects of other antihypertensive agents and may increase serum levels of digoxin. Quinidine levels may decrease with co-administration. Always inform your healthcare provider of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended, as it may increase the risk of adverse effects such as hypotension.
Overdose
Symptoms of Adalat overdose may include severe hypotension, bradycardia or tachycardia, and metabolic acidosis. In cases of suspected overdose, seek immediate medical attention. Treatment is primarily supportive and may include cardiovascular monitoring, vasopressors, intravenous calcium gluconate, and atropine for bradycardia. Gastric lavage may be considered if ingestion was recent. Due to the extended-release formulation, monitoring should continue for at least 24 hours.
Storage
Store Adalat at room temperature (15–30°C or 59–86°F), in a dry place away from direct light and moisture. Keep the medication in its original container, tightly closed, and out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Proper disposal of unused medication is recommended through a medicine take-back program or according to local guidelines.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual medical conditions and responses to therapy may vary. Never disregard professional medical advice or delay seeking it based on information provided here.
Reviews
Clinical studies and patient reports consistently affirm Adalat’s effectiveness in controlling blood pressure and reducing angina symptoms. Many users note improved quality of life and minimal side effects with appropriate dosing. Healthcare professionals appreciate its reliability and well-documented history in cardiovascular care. However, responses can vary, and some patients may require dosage adjustments or alternative therapies based on tolerance and efficacy.